TCL Archive Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI. November 12, 2004
TCL Archive Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge March 27, 1981
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983